Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
Preceding the joint meeting of the 19th annual Diabetic Neuropathy Study Group of the European Association for the Study of Diabetes (NEURODIAB) and the 8th International Symposium on Diabetic Neuropathy in Toronto, Canada, 13–18 October 2009, expert panels were convened to provide updates on classification, definitions, diagnostic criteria, and treatments of diabetic peripheral neuropathies (DPNs), autonomic neuropathy, painful DPNs, and structural alterations in DPNs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prediabetes has been found to be associated with decreased heart rate variability61 (HRV – a marker of parasympathetic function),62–65, decreased postural changes in heart rate,62 increased prevalence of erectile dysfunction among men,66 and a worse profile in tests of sympathetic and parasympathetic function.67”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies in prediabetes and sensorimotor neuropathy 68–70 suggest that IGT and early diabetic neuropathy may involve small demyelinated fibres.61”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Diabetic neuropathy (distal symmetric polyneuropathy (DSPN)) causes bilateral decrease or loss of ATR.”
From The usefulness of deep tendon reflexes in the diagnosis of lumbar spine diseases: a narrative review (2024) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“These criteria include obvious bilateral loss or reduction of the ATR.”
From The usefulness of deep tendon reflexes in the diagnosis of lumbar spine diseases: a narrative review (2024) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“No consistent evidence is available to suggest that prediabetes is associated with measurements of orthostatic blood pressure changes,63 which is a late marker of diabetic neuropathy,61 or with decreased expiratory-inspiratory ratio or change in heart rate during breathing.63”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Boulton, A. J. M., Vinik, A. I., Arezzo, J. C., Bril, V., Feldman, E. L., Freeman, R., Malik, R. A., Maser, R. E., Sosenko, J. M., & Ziegler, D. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.956 · Cited by 1,859
Self-citationDyck, P. J., Kratz, K. M., Karnes, J. L., Litchy, W. J., Klein, R., Pach, J. M., Wilson, D. M., O'Brien, P. C., & Melton, L. J. (1993) · Neurology · doi:10.1212/wnl.43.4.817 · Cited by 1,482 · cited 3×
“The typical DPN is a chronic, symmetrical, length-dependent sensorimotor polyneuropathy (DSPN) and is thought to be the most common variety (1).”
BackgroundSelf-citationVascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323
Self-citationDiabetic cardiovascular autonomic neuropathy
Vinik, A. I., & Ziegler, D. (2007) · Circulation · doi:10.1161/circulationaha.106.634949 · Cited by 1,255 · cited 3×
“Some pathogenetic mechanisms may link CAN to cardiovascular dysfunction and diabetic complications (34).”
BackgroundInfluentialSelf-citationGæde, P., Vedel, P., Parving, H.-H., & Pedersen, O. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07368-1 · Cited by 981
A systematic review of antidepressants in neuropathic pain
McQuay, H. J., Tramér, M., Nye, B. A., Carroll, D., Wiffen, P. J., & Moore, R. A. (1996) · Pain · doi:10.1016/s0304-3959(96)03140-5 · Cited by 930
Boulton, A. J. M., Malik, R. A., Arezzo, J. C., & Sosenko, J. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1458 · Cited by 913 · cited 3×
“The symptoms are distal, symmetrical, often associated with nocturnal exacerbations, and commonly described as prickling, deep aching, sharp, like an electric shock, and burning (13) with hyperalgesia and frequently allodynia upon examination (17).”
BackgroundInfluentialSelf-citationLauria, G., Hsieh, S. T., Johansson, O., Kennedy, W. R., Leger, J. M., Mellgren, S. I., Nolano, M., Merkies, I. S. J., Polydefkis, M., Smith, A. G., et al. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03023.x · Cited by 864
Self-citationSima, A. A. F., Thomas, P. K., Ishii, D., & Vinik, A. (1997) · Diabetologia · doi:10.1007/bf03168192 · Cited by 822
Self-citation
Research works printed but not linked: 1
- Appell, 1991, DM and Other Peripheral Neuropathies Affecting Lower Urinary Tract Function, 365
Cited by
Items 801–900 of 1,002
Shayea, A. M. F., Mousa, A. M. A., Renno, W. M., Nadar, M. S., Qabazard, B., & Yousif, M. H. M. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa127 · Cited by 27
Immune Axonal Neuropathies Associated With Systemic Autoimmune Rheumatic Diseases
Tulbă, D., Popescu, B. O., Manole, E., & Băicuş, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.610585 · Cited by 27
“Interestingly, AMAN and AMSAN have been reported as initial manifestations of SLE in 4 cases and preceding the diagnosis of SLE in 2 cases (Thakolwiboon et al., 2019).”
BackgroundBönhof, G. J., Herder, C., & Ziegler, D. (2021) · Current Diabetes Reviews · doi:10.2174/1573399817666210412123740 · Cited by 29
Cardiovascular Disease Predicts Severe Hypoglycemia in Patients with Type 2 Diabetes
Yun, J., Ko, S., Ko, S.-H., Song, K., Yoo, K., Yoon, K., Park, Y., & Ahn, Y. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.6.498 · Cited by 25
Influence of Sex on Cognition and Peripheral Neurovascular Function in Diabetic Mice
Fan, B., Liu, X., Szalad, A., Wang, L., Zhang, R., Chopp, M., & Zhang, Z. G. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00795 · Cited by 25
Zinglersen, A. H., Iversen, K. K., Leffers, H. C. B., Laugesen, E., Fleischer, J., & Jacobsen, S. (2021) · Lupus Science & Medicine · doi:10.1136/lupus-2021-000507 · Cited by 24
Kim, K., Oh, T. J., Cho, H. C., Lee, Y. K., Ahn, C. H., Koo, B. K., Moon, J. H., Choi, S. H., & Jang, H. C. (2021) · Scientific Reports · doi:10.1038/s41598-021-03870-z · Cited by 25
Croosu, S. S., Hansen, T. M., Røikjer, J., Mørch, C. D., Ejskjær, N., & Frøkjær, J. B. (2022) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1835-1877 · Cited by 25
Uchida, T., Ueno, H., Konagata, A., Taniguchi, N., Kogo, F., Nagatomo, Y., Shimizu, K., Yamaguchi, H., & Shimoda, K. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01370-z · Cited by 24
“Diabetic neuropathy was defined according to the diagnostic criteria of the Toronto Diabetic Neuropathy Expert Group [21].”
MethodSyed, O., Jancic, P., & Knežević, N. N. (2023) · Pharmaceuticals · doi:10.3390/ph16060801 · Cited by 28
“This clinical presentation is often a sign of small nerve fiber involvement [3,4,6,8].”
BackgroundMeling, S., Tjora, E., Eichele, H., Ejskjær, N., Carlsen, S., Njølstad, P. R., Brock, C., & Søfteland, E. W. (2023) · Journal of Diabetes Research · doi:10.1155/2023/4441115 · Cited by 26
“The condition is defined as a disorder of the autonomic nervous system in the setting of diabetes or metabolic derangements of prediabetes, after the exclusion of other causes, and may affect the cardiovascular, gastrointestinal, and genitourinary systems, as well as sudomotor function [2].”
BackgroundResultInfluentialHamasaki, H. (2023) · Healthcare · doi:10.3390/healthcare11192668 · Cited by 27
“The Toronto Consensus Panel on Diabetic Neuropathy defined CAN as “impairment of cardiovascular autonomic control in patients with established diabetes after excluding other causes” [4–6].”
BackgroundKasznicki, J. (2014) · Archives of Medical Science · doi:10.5114/aoms.2014.42588 · Cited by 27
“Distal symmetric polyneuropathy develops on a background of chronic hyperglycemia and total hyperglycemic exposure seems to be the most important factor [8].”
InfluentialPerioperative implications of the patient with autonomic dysfunction
McGrane, S., Atria, N. P., & Barwise, J. (2014) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000072 · Cited by 24
“Diabetic autonomic neuropathy (DAN) is defined as a disorder of the ANS in the setting of diabetes mellitus or the metabolic derangements of prediabetes after the exclusion of other causes [12].”
BackgroundFleischer, J., Yderstræde, K. B., Gulichsen, E. H., Jakobsen, P. E., Lervang, H. H., Eldrup, E., Nygaard, H., Tarnow, L., & Ejskjær, N. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814528616 · Cited by 35
“At least 2 of the 3 tests should be performed to provide adequate diagnostic information.(15) All the heart rate-based tests were evaluated according to agedependent cutoff levels.”
MethodPeripheral sensory neuropathy in type 2 diabetes patients: A case control study in Accra, Ghana
Yeboah, K., Puplampu, P., Boima, V., Antwi, D. A., Gyan, B., & Amoah, A. G. B. (2016) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2016.07.001 · Cited by 31
Wu, Y., Tseng, P. H., Huang, H.-W., Hu, J., Juan, C.-H., Hsu, K., & Lin, C. K. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00479 · Cited by 27
Sharma, S., Tobin, V., Vas, P. R. J., Malik, R. A., & Rayman, G. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193452 · Cited by 26
Self-citationIsing, E., Dahlin, L. B., & Larsson, H. E. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196243 · Cited by 24
Du, H., Liu, Z., Tan, X., Ma, Y., & Gong, Q. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.12.040 · Cited by 24
Hata, M., Omi, M., Kobayashi, Y., Nakamura, N., Miyabe, M., Hiramatsu‐Ito, M., Makino, E., Kanada, S., Saiki, T., Ohno, T., et al. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01758-9 · Cited by 27
Glycemic Variability and Diabetic Neuropathy in Young Adults With Type 1 Diabetes
Christensen, M. M. B., Hommel, E. E., Jørgensen, M. E., Fleischer, J., & Hansen, C. S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00644 · Cited by 24
Sirisha, A., Gaur, G. S., Pal, P., Bobby, Z., Balakumar, B., & Pal, G. K. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245395 · Cited by 29
“Decreased nerve conduction velocity (NCV), which is frequently subclinical, is considered to be the first objective quantitative indicator of polyneuropathy [3].”
BackgroundImpact of the metabolic syndrome on peripheral nerve structure and function in type 2 diabetes
Issar, T., Tummanapalli, S. S., Borire, A. A., Kwai, N. C. G., Poynten, A. M., Arnold, R., Markoulli, M. P., & Krishnan, A. V. (2021) · European Journal of Neurology · doi:10.1111/ene.14805 · Cited by 24
“neuropathy: the presence of nerve conduction abnormality and a sign or symptom of neuropathy [13].”
BackgroundAndo, A., Miyamoto, M., Saito, N., Kotani, K., Kamiya, H., Ishibashi, S., & Tavakoli, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.653277 · Cited by 24
Spinal Inhibitory Dysfunction in Patients With Painful or Painless Diabetic Neuropathy
Worthington, A., Kalteniece, A., Ferdousi, M., D’Onofrio, L., Dhage, S. S., Azmi, S., Adamson, C., Hamdy, S., Malik, R. A., Calcutt, N. A., et al. (2021) · Diabetes Care · doi:10.2337/dc20-2797 · Cited by 26
Self-citationExercise in the Prevention and Treatment of Type 2 Diabetes
Kirwan, J. P., Heintz, E. C., Rebello, C. J., & Axelrod, C. L. (2023) · Wiley eBooks · doi:10.1002/cphy.c220009 · Cited by 26
Chang, K., Pai, Y., Lin, C., Lee, I., & Chang, M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0287373 · Cited by 28
“Based on the current diagnostic criteria for DPN, those patients in the DPN group were supposed to be categorized as possible or probable DPN [28].”
BackgroundMethodThe pathogenesis of painful diabetic neuropathy and clinical presentation
Jensen, T. S. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110753 · Cited by 35
Li, X., Hao, W., & Yang, N. (2024) · Scientific Reports · doi:10.1038/s41598-024-54704-7 · Cited by 24
Røikjer, J., Wegeberg, A., Nikontovic, A., Brock, C., & Vestergaard, P. (2024) · Primary care diabetes · doi:10.1016/j.pcd.2024.08.006 · Cited by 27
The ECG Vertigo in Diabetes and Cardiac Autonomic Neuropathy
Voulgari, C., Tentolouris, N., & Stefanadis, C. (2011) · Experimental Diabetes Research · doi:10.1155/2011/687624 · Cited by 25
“CAN embraces exercise intolerance, intraoperative cardiovascular liability, orthostatic tachycardia and bradycardia syndromes, and silent myocardial ischemia [63].”
BackgroundThe Preventive Effect of IL-1beta Antagonist on Diabetic Peripheral Neuropathy
Zheng, H., Han, L., Ji, L., Zhao, W., Liu, X., Zhang, Q., Zhu, X., Li, Q., Li, Y., Xiong, Q., et al. (2019) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530319666191022114139 · Cited by 23
Kimura, T., Okamura, T., Iwai, K., Hashimoto, Y., Senmaru, T., Ushigome, E., Hamaguchi, M., Asano, M., Yamazaki, M., & Fukui, M. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001027 · Cited by 26
Pope, Z., Gabriel, K. P., Whitaker, K. M., Chen, L. Y., Schreiner, P. J., Jacobs, D. R., Sternfeld, B., Carr, J. J., Lloyd‐Jones, D. M., & Pereira, M. A. (2020) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002259 · Cited by 29
Vági, O. E., Svébis, M. M., Domján, B. A., Körei, A. E., Istenes, I., Putz, Z., Mészáros, S., Hajdú, N., Békeffy, M. Z., Tesfaye, S. H., et al. (2021) · Journal of Diabetes Research · doi:10.1155/2021/6662159 · Cited by 28
“CAN was assessed with gold standard cardiovascular reflex tests using Ewing’s battery [6].”
BackgroundMethodSelf-citationLin, X., Chen, C., Liu, Y., Yu, P., Chen, Z., Huang, H., & Xu, L. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.709114 · Cited by 23
Lie, H. C., Anderssen, S. A., Rueegg, C. S., Raastad, T., Grydeland, M., Thorsen, L., Stensrud, T., Edvardsen, E., Larsen, M. H., Torsvik, I. K., et al. (2022) · JMIR Research Protocols · doi:10.2196/35838 · Cited by 21
Galosi, E., Falco, P., Pietro, G. D., Leone, C. M., Esposito, N., Stefano, G. D., Stefano, G. D., & Truini, A. (2022) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12513 · Cited by 25
“Skin biopsy, thermal threshold assessment with quantitative sensory testing (QST), and nociceptive evoked potentials are considered the reference standard tests for diagnostic confirmation.(4,5) However, these techniques are time-consuming, not widely available in primary healthcare settings and neurological outpatien…”
BackgroundMethodZhang, H., Carvalho, V., Zhang, Z., Zhou, W. P., Jiang, X., Zhao, W., Chen, Y., He, M., Zhang, Y., Wang, W., et al. (2023) · Journal of Diabetes Research · doi:10.1155/2023/3060013 · Cited by 23
“DPN patients were diagnosed based on the Toronto consensus of diabetic neuropathy [30].”
BackgroundAkbar, M., Wandy, A., Soraya, G. V., Goysal, Y., Lotisna, M., & Basri, M. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18184 · Cited by 29
Lange‐Maia, B. S., Newman, A. B., Cauley, J. A., Boudreau, R. M., Jakicic, J. M., Caserotti, P., Glynn, N. W., Harris, T. B., Kritchevsky, S. B., Schwartz, A. V., et al. (2015) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2015.08.423 · Cited by 24
Self-citationPeripheral neuropathy: a complication of systemic sclerosis
Frech, T., Smith, G., Reily, M., Chamberlain, J. J., Murtaugh, M. A., Penrod, J., Battistone, M. J., & Stults, B. M. (2013) · Clinical Rheumatology · doi:10.1007/s10067-013-2206-6 · Cited by 23
Terashima, T., Kojima, H., & Chan, L. (2011) · The FASEB Journal · doi:10.1096/fj.11-186262 · Cited by 26
Jurado, J., Ybarra, J., Romeo, J. H., García-Gil, M., & Zabaleta‐del‐Olmo, E. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.02.011 · Cited by 23
Serum fibroblast growth factor 21 concentrations in type 2 diabetic retinopathy patients
Esteghamati, A., Momeni, A., Abdollahi, A. A., Khandan, A., Afarideh, M., Noshad, S., & Nakhjavani, M. (2016) · Annales d Endocrinologie · doi:10.1016/j.ando.2016.01.005 · Cited by 24
A rapid decline in corneal small fibers and occurrence of foot ulceration and Charcot foot
Dehghani, C., Russell, A. W., Perkins, B. A., Malik, R. A., Pritchard, N., Edwards, K. P., Shahidi, A. M., Srinivasan, S., & Efron, N. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.07.004 · Cited by 23
“Introduction Diabetic peripheral neuropathy (DPN), a common and chronic complication of diabetes, can lead to foot ulceration, Charcot foot and amputation with a significant impact on the quality Correspondence to: Cirous Dehghani.”
InfluentialSelf-citationAssessment of the cardiovascular and gastrointestinal autonomic complications of diabetes
Brock, C., Brock, B., Pedersen, A. G., Drewes, A. M., Jessen, N., & Farmer, A. D. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i16.321 · Cited by 24
Epps, J., & Smart, N. A. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0444-z · Cited by 24
“Diabetic sensorimotor polyneuropathy (DSPN) is initially subclinical, and progresses to overt clinical symptoms and increased severity [164].”
BackgroundMight genetics play a role in understanding and treating diabetic polyneuropathy?
Spallone, V. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2882 · Cited by 26
“The diagnostic approach to DPN is mainly based on clinical appreciation of symptoms and signs of sensorimotor dysfunction and deficit and on nerve conduction studies.(13) Quantitative sensory testing for thermal sensation, devices tracking sudomotor function, skin biopsy, and corneal confocal microscopy have more rece…”
MethodSelf-citationTNF-Alpha in Peripheral Neuropathy Patients with Impaired Glucose Regulation
Li, X., Zhu, J., Liu, N., Liu, J., & Zhang, Z. (2017) · Journal of Diabetes Research · doi:10.1155/2017/7024024 · Cited by 24
“The peripheral neuropathy was diagnosed according to the criteria of American Diabetes Association (ADA) in 2010 [12]; the clinical symptoms and signs and nerve conduction abnormalities in IGR-PN group were in accordance with the diagnosis of distal symmetrical polyneuropathy.”
MethodHan, S. H., & Park, J. W. (2017) · Medicine · doi:10.1097/md.0000000000008611 · Cited by 23
Hirayasu, K., Sasaki, H., Kishimoto, S., Kurisu, S., Noda, K., Ogawa, K., Tanaka, H., Sakakibara, Y., Matsuno, S., Furuta, H., et al. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12818 · Cited by 23
Afarideh, M., Esteghamati, V. Z., Ganji, M., Heidari, B., Esteghamati, S., Lavasani, S., Ahmadi, M., Tafakhori, A., Nakhjavani, M., & Esteghamati, A. (2019) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2019.01.003 · Cited by 24
Diabetic Polyneuropathy – Advances in Diagnosis and Intervention Strategies
Tesfaye, S. H., & SLOAN, G. P. (2020) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2020.16.1.15 · Cited by 30
“There are a number of established and emerging markers of DPN, including skin biopsy and corneal confocal microscopy.(17) The latter provides a non-invasive quantitative method of detecting DPN and has been found to be more sensitive in assessing nerve repair than other standard measures.”
BackgroundMethodSelf-citationKarlsson, P., Gylfadottir, S. S., Kristensen, A. G., Ramirez, J. D., Cruz, P. F., Le, N., SHILLO, P. R., Tesfaye, S. H., Rice, A. S. C., Tankişi, H., et al. (2021) · Diabetologia · doi:10.1007/s00125-020-05352-9 · Cited by 25
Self-citationThe Role of Vascular Lesions in Diabetes Across a Spectrum of Clinical Kidney Disease
Rodríguez-Rodríguez, R., Hojs, R., Trevisani, F., Morales, E., Fernández, G., Bevc, S., Corona, C. M. C., Cruzado, J. M., Quero, M., Navarro-Díaz, M., et al. (2021) · Kidney International Reports · doi:10.1016/j.ekir.2021.06.001 · Cited by 24
“Never 36 (41) 15 (42) 15 (48) 6 (30) Current 14 (16) 5 (14) 8 (26) 1 (5) Previous 37 (43) 16 (44) 8 (26) 13 (65)”
AANEM policy statement on electrodiagnosis for distal symmetric polyneuropathy
(2017) · Muscle & Nerve · doi:10.1002/mus.26003 · Cited by 23
Thermal Threshold: Research Study on Small Fiber Dysfunction in Distal Diabetic Polyneuropathy
Jiménez-Cohl, P., Grekin, C., Leyton, C., Vargas, C., & Villaseca, R. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600122 · Cited by 23
Jane, S., Lin, M., Chiu, W., Beaton, R. D., & Chen, M. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011897 · Cited by 24
Development and Progression of Polyneuropathy Over 5 Years in Patients With Type 2 Diabetes
Brask‐Thomsen, P. K., Itani, M., Karlsson, P., Kristensen, A. G., Krøigård, T., Jensen, T. S., Tankişi, H., Sindrup, S. H., Finnerup, N. B., & Gylfadottir, S. S. (2024) · Neurology · doi:10.1212/wnl.0000000000209652 · Cited by 25
Assessment of small fiber neuropathy to predict future risk of type 2 diabetes
Müller, G., Parfentyeva, E., Olschewsky, J., Bornstein, S. R., & Schwarz, P. E. H. (2013) · Primary care diabetes · doi:10.1016/j.pcd.2013.08.001 · Cited by 23
Farooqi, M. A., Lovblom, L. E., Lysy, Z., Ostrovski, I., Halpern, E. M., Ngo, M., Ng, E., Orszag, A., Breiner, A., Bril, V., et al. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.12.023 · Cited by 23
“DSP was established using consensus criteria (England et al., 2005; Tesfaye et al., 2010) that called for the presence of clinical and electrophysiological abnormalities.”
BackgroundMethodStatic and Dynamic Pupillary Responses in Patients with Different Stages of Diabetic Retinopathy
Kızıltoprak, H., Tekin, K., Şekeroğlu, M. A., Yetkin, E., Doğuizi, S., & Yılmazbaş, P. (2019) · Neuro-Ophthalmology · doi:10.1080/01658107.2019.1671465 · Cited by 22
“It negatively impacts quality of life and overall survival in DM patients.(7,8) Hence, early clinical detection and precautions are necessary to help people with DM to live better.”
BackgroundSmall Fiber Neuropathy: Clinicopathological Correlations
Pál, E., Fülöp, K., Tóth, P., Deli, G., Pfund, Z., Janszky, J., & Komoly, S. (2020) · Behavioural Neurology · doi:10.1155/2020/8796519 · Cited by 24
“According to the diagnostic criteria, all of our patients belonged to the definite SFN category [12].”
BackgroundMigisha, R., Agaba, D. C., Katamba, G., Kwaga, T., Tumwesigye, R., Miranda, S. L., Muyingo, A., & Siedner, M. J. (2020) · Global Heart · doi:10.5334/gh.765 · Cited by 26
“Cardiovascular autonomic neuropathy (CAN) is defined as an impairment of cardiovascular autonomic control in people with diabetes with other causes excluded [7, 8].”
BackgroundReducing monocarboxylate transporter MCT1 worsens experimental diabetic peripheral neuropathy
Jha, M. K., Ament, X. H., Yang, F. W., Liu, Y., Polydefkis, M. J., Pellerin, L., & Morrison, B. M. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113415 · Cited by 27
Ko, Y., Lee, C., Wu, C., & Huang, Y. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14576 · Cited by 23
Pan, J., Yan, X., Li, F., Zhang, Y., Jiang, L., & Wang, C. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13652 · Cited by 22
Bangar, N. S., Gvalani, A., Ahmad, S., Khan, M. S., & Tupe, R. S. (2022) · Glycobiology · doi:10.1093/glycob/cwac060 · Cited by 27
Al-Saoudi, E., Christensen, M. M. B., Nawroth, P. P., Fleming, T. H., Hommel, E. E., Jørgensen, M. E., Fleischer, J., & Hansen, C. S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.891442 · Cited by 28
Pang, C., Yu, H., Cai, Y., Song, M., Feng, F., Gao, L., Li, K., Chen, Y., Xie, J., Cheng, Y., et al. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3679 · Cited by 24
“Diabetic peripheral neuropathy was diagnosed with both neurological symptoms/signs and nerve conduction abnormalities.(29) Symptoms and signs, such as numbness, tingling, unsteadiness, prickling or burning pain in the legs and feet, ankle reflexes, distal sensation, touch sensation, thermal discrimination, pinprick se…”
Zhang, H., Chen, Y., Zhu, W., Niu, T., Song, B., Wang, W., Wang, W., & Zhang, H. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01865-5 · Cited by 24
“The Toronto Consensus criteria was used to diagnosis the presence of DPN [17].”
MethodExosomes as biomarkers and therapy in type 2 diabetes mellitus and associated complications
Satyadev, N., Rivera, M. I., Nikolov, N. K., & Fakoya, A. O. J. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1241096 · Cited by 22
Reproducibility of peroneal motor nerve conduction measurement in older adults
Ward, R. E., Boudreau, R. M., Vinik, A. I., Živković, S., Njajou, O. T., Satterfield, S., Harris, T. B., Newman, A. B., & Strotmeyer, E. S. (2012) · Clinical Neurophysiology · doi:10.1016/j.clinph.2012.07.027 · Cited by 22
“…symptoms; however, the Diabetic Neuropathy Study Group of the European Association for the Study of Diabetes (NEURODIAB) and the International Symposium on Diabetic Neuropathy endorse the use of NC studies as a measure of early nerve decline in pre-symptomatic individuals (Tesfaye et al., 2010).”
Self-citationFactors associated with glycemic variability in Japanese patients with diabetes
Tanaka, C., Saisho, Y., Tanaka, K., Kou, K., Tanaka, M., Meguro, S., Irie, J., Jo, R., Kawai, T., & Itoh, H. (2013) · Diabetology International · doi:10.1007/s13340-013-0129-8 · Cited by 26
“Moreover, both age and diabetes duration have been reported to be associated with increased incidence of autonomic neuropathy, which affects glycemic variability [27].”
Lee, K. A., Jin, H. Y., Baek, H. S., & Park, T. S. (2013) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.59.437 · Cited by 22
Liu, Q., Pang, Z., Liu, R., He, G., Cui, J., & Yin, X. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.04.026 · Cited by 22
Maffei, L., Premrou, V., Roldan, P., Copetti, M., Pellegrini, F., Rossi, M. C., & Vespasiani, G. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814527818 · Cited by 27
“Use of the vibration perception threshold (VPT) is a simple way of detecting large-fiber dysfunction, thus identifying individuals with diabetes at risk of ulceration.(1-2) Nevertheless, poor standardization of measurement limits its use in clinical practice;(3-5) furthermore, the unique normality threshold of 25 V is…”
BackgroundScreening and Treatment by the Primary Care Provider of Common Diabetes Complications
Gilbert, M. P. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.09.002 · Cited by 27
Fensom, B., Harris, C., Thompson, S. E., Almehthel, M. S., & Thompson, D. M. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.10.011 · Cited by 23
SUDOSCAN, an effective tool for screening chronic kidney disease in patients with type 2 diabetes
Mao, F., Liu, S., Qiao, X., Zheng, H., Xiong, Q., Wen, J., Zhang, S., Zhang, Z., Ye, H., Shi, H., et al. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4689 · Cited by 22
“The majority of guidelines recommend regular screening for complications and risk factors in patients with diabetes, including eye, foot, blood and urine examinations (1,3,28,34,35).”
Zafeiri, M., Tsioutis, C., Kleinaki, Z., Manolopoulos, P. P., Ioannidis, I., & Dimitriadis, G. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0741-6937 · Cited by 23
Diagnosing and managing diabetic somatic and autonomic neuropathy
Azmi, S., Ferdousi, M., Kalteniece, A., Almuhannadi, H., Al‐Mohamedi, A., Hadid, N. H., Mahmoud, S., Bhat, H., Gad, H., Khan, A., et al. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819826890 · Cited by 23
Self-citationWeng, Y., Tsai, S., Lyu, R., Chu, C., Ro, L., Liao, M., Chang, H., Chen, C., Hwang, J., & Kuo, H. (2020) · Journal of Diabetes Research · doi:10.1155/2020/6356459 · Cited by 22
“Nerve conduction studies (NCS) were performed by conventional supramaximal percutaneous stimulation of the limbs and surface recordings according to the Toronto consensus recommendation for diagnosing diabetic peripheral neuropathies [14].”
BackgroundMethodInfluentialIs there cardiac autonomic neuropathy in prediabetes?
Zilliox, L. A., & Russell, J. W. (2020) · Autonomic Neuroscience · doi:10.1016/j.autneu.2020.102722 · Cited by 25
“Diagnostic criteria and staging of CAN has been suggested by the Toronto Consensus Panel: (1) the presence of one abnormal cardiovagal test identifies possible or early CAN, (2) at least 2 abnormal heart rate tests are required for a definite diagnosis of CAN, and (3) orthostatic hypotension in addition to heart rate…”
BackgroundHistory of lower-limb complications and risk of cancer death in people with type 2 diabetes
Mohammedi, K., Harrap, S. B., Mancia, G., Marre, M., Poulter, N. R., Chalmers, J. P., & Woodward, M. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01198-y · Cited by 25
“Peripheral sensory neuropathy was defined as the presence at baseline of at least two neurological abnormalities [27]: disturbance of the light touch sensation, abolition of ankle or knee reflex or chronic (at least 6 weeks) foot ulceration.”
BackgroundRattanatham, R., Settasatian, N., Komanasin, N., Kukongviriyapan, U., Sawanyawisuth, K., Intharaphet, P., Senthong, V., & Settasatian, C. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0101 · Cited by 24
“Definition and assessment for diabetic complications have detailed description in the Supplementary methods [33-36].”
MethodWhat Is in the Field for Genetics and Epigenetics of Diabetic Neuropathy: The Role of MicroRNAs
Spallone, V., Ciccacci, C., Latini, A., & Borgiani, P. (2021) · Journal of Diabetes Research · doi:10.1155/2021/5593608 · Cited by 23
“Finally, the GG genotype was associated with worse values of neuropathic de fi cit score, i.e., Michigan Diabetic Neuropathy Score ( p = 0 : 017 ), vibration perception threshold ( p = 0 : 01 ), thermal thresholds ( p = 0 : 01 ), and CART score ( p 0 : 001 ): in a multiple linear regression, the GG genotype was the mai…”
MethodInfluentialSelf-citationDetection of neuropathy using a sudomotor test in type 2 diabetes
Maarek, A., Rao, G. H. R., & Gandhi, P. G. (2015) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s75857 · Cited by 22
Sheshah, E., Madanat, A., Al-Greesheh, F., Al-Qaisi, D., Al-Harbi, M. Y., Aman, R., AL-Ghamdi, A. A., & Almadani, K. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-016-0252-8 · Cited by 23
“Participants were then classified as having normal, subclinical (ie nerve conduction abnormality but without symptoms or signs of DPN) or confirmed DPN as described by Tesfaye S et al 2010 [1].”
MethodCardio-Ankle Vascular Index and Indices of Diabetic Polyneuropathy in Patients with Type 2 Diabetes
Ando, A., Miyamoto, M., Kotani, K., Okada, K., Nagasaka, S., & Ishibashi, S. (2017) · Journal of Diabetes Research · doi:10.1155/2017/2810914 · Cited by 23
Neuropathy in Diabetes: “One Cannot Begin It Too Soon”
Pafili, K., Παπάνας, Ν., & Ziegler, D. (2018) · Angiology · doi:10.1177/0003319717751759 · Cited by 27
Pennathur, S., Jaiswal, M., Vivekanandan-Giri, A., White, E. A., Ang, L., Raffel, D. M., Rubenfire, M., & Pop-Busui, R. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.03.008 · Cited by 21
“Neuropathies are among the most prevalent and debilitating complications of diabetes mellitus (4).”
BackgroundJermendy, G., Kempler, P., Abonyi‐Tóth, Z., Rokszin, G., & Wittmann, I. (2016) · Orvosi Hetilap · doi:10.1556/650.2016.30519 · Cited by 26
Self-citationAida, A., Svensson, T., Svensson, A. K., Urushiyama, H., Okushin, K., Oguri, G., Kubota, N., Koike, K., Nangaku, M., Kadowaki, T., et al. (2020) · JMIR mhealth and uhealth · doi:10.2196/20982 · Cited by 21
Khan, K. S., Pop‐Busui, R., Devantier, L., Kristensen, A. G., Tankişi, H., Dalgas, U., Overgaard, K., & Andersen, H. (2020) · Diabetic Medicine · doi:10.1111/dme.14470 · Cited by 25
Huang, L., Shen, X., Huang, L., Yan, S., & Wu, P. (2021) · Journal of International Medical Research · doi:10.1177/03000605211044366 · Cited by 22
“Nearly twothirds of patients with DM who develop DN have poor quality of life.(2) Previous studies have demonstrated the effects of intensive glucose control on DN progression in patients with type 1 DM.”
BackgroundSUDOSCAN, an Innovative, Simple and Non-Invasive Medical Device for Assessing Sudomotor Function
Gavan, D. E., Gavan, A. D., Bondor, C. I., Florea, B., Bowling, F. L., Inceu, G., & Colobățiu, L. (2022) · Sensors · doi:10.3390/s22197571 · Cited by 25
“Sudomotor function is largely regulated by small, unmyelinated cholinergic sympathetic C ‐ fibers that also regulate cardiovascular autonomic function, which may be affected earlier in patients experiencing DN [12].”
BackgroundKaredath, J., Batool, S. A., Arshad, A., Khalique, S., Raja, S., Lal, B., Chunchu, V. A., & Hirani, S. (2022) · Cureus · doi:10.7759/cureus.31783 · Cited by 21
“Diabetic neuropathy is a serious complication of type 2 diabetes mellitus, and it can lead to devastating symptoms such as unbearable and unremitting pain and can have severe life-threatening outcomes including the “diabetic foot” [19].”
Background
Metadata
- Authors
- Tesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., Bernardi, L., Valensi, P., & on behalf of the Toronto Diabetic Neuropathy Expert Group
- Affiliations
- Sheffield Teaching Hospitals NHS Foundation Trust (GB)
- University of Manchester (GB)
- Mayo Clinic (US)
- Beth Israel Deaconess Medical Center (US)
- The University of Adelaide (AU)
- I Department of Medicine, Semmelweis University, Budapest, Hungary;
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- University of Rome Tor Vergata (IT)
- Eastern Virginia Medical School (US)
- University of Pavia (IT)
- Assistance Publique – Hôpitaux de Paris (FR)
- Corresponding author
- Tesfaye, Solomon
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-10-01
- Volume
- 33
- Issue
- 10
- Pages
- 2285-2293
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2945176
- OpenAlex
- W2113384757
- Cited by
- 2,690
- References
- 77
- Citations by year
- 2026: 180 · 2025: 190 · 2024: 221 · 2023: 199 · 2022: 226 · 2021: 235 · 2020: 220 · 2019: 175 · 2018: 189 · 2017: 155 · 2016: 157 · 2015: 127 · 2014: 151 · 2013: 102 · 2012: 94
- FWCI
- 8.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- SZTE Publicatio Repozitórium (University of Szeged) (acceptedVersion, other-oa)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, cc-by-nc-nd)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion, cc-by-nc-nd)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by-nc-nd)
- Research Explorer (The University of Manchester) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- Eli Lilly and Company
- Louisiana State University
- Eastern Virginia Medical School
- Semmelweis Egyetem
- Gentofte Hospital
- University of Toronto
- Odense Universitetshospital
- Szegedi Tudományegyetem
- Leibniz-Gemeinschaft
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
- Keywords
- diabetic neuropathy, diabetic peripheral neuropathy, diabetic autonomic neuropathy, diabetic neuropathic pain, neuropathy classification, diagnostic criteria, neuropathy treatment
- MeSH terms
- Diabetic Neuropathies, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.